Serum metabolic profiling of targeted bile acids reveals potentially novel biomarkers for primary biliary cholangitis and autoimmune hepatitis

doi:10.3748/wjg.v28.i39.5764

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 28, Issue 39

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4316)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-10) series, Tables (1-7) series.

Item

Count

PDF

214

WORD

HTML

2474

Figures (1-10)

303

Tables (1-7)

242

Sum=3286

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

248

Download

782

Sum=1030

Oct 21, 2022 (publication date) through Jul 5, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastroenterol. Oct 21, 2022; 28(39): 5764-5783
Published online Oct 21, 2022. doi: 10.3748/wjg.v28.i39.5764

Full Size Figure Download Figure

Figure 8 Receiver operating characteristic curve analysis. A: Lithocholic acid (LCA), sum of LCA and taurolithocholic acid, chenodeoxycholic acid; B: Common clinical biochemical indicators.

Citation: Ma ZH, Wang XM, Wu RH, Hao DL, Sun LC, Li P, Niu JQ. Serum metabolic profiling of targeted bile acids reveals potentially novel biomarkers for primary biliary cholangitis and autoimmune hepatitis. World J Gastroenterol 2022; 28(39): 5764-5783
URL: https://www.wjgnet.com/1007-9327/full/v28/i39/5764.htm
DOI: https://dx.doi.org/10.3748/wjg.v28.i39.5764